Table 2 NiV serum neutralization titers in control or m102.4-treated AGMs.

Reciprocal serum dilution at which 50% of virus was neutralized. NT, not tested.

Treatment regimenSubject no.Day 0*Day 3Day 5Day 7Day 15Days 30–34
Days 1 and 3R300<2051205120512051202560
Y083<2051205120512051202560
R429<2051205120512051201280
O7245<202560512051202560640
Days 3 and 5R183<20<205120512051201280
Y809<20<205120512051202560
R145<20<205120512051205120
O7823<20<2051201024051201280
Days 5 and 7O7383<20NTNT512051202560
O7818<20NTNT512051202560
O918745<20NTNT512051202560
R198<20NTNT512051202560
NoneR272<20NTNT<20
V753<20NTNT<20
R318<20NTNT<20
O20121<20NTNT<20

*Day after NiV challenge.